Australia is a step closer to eliminating hepatitis B and C as public health challenges by 2030 with the release of two new national strategies today.
The new National Hepatitis B and Hepatitis C Strategies 2026 to 2030 set the next stage of Australia's world-leading national response - strengthening prevention, improving early diagnosis and ensuring people can access treatment and care.
Following extensive national consultation, the strategies build on past successes. They focus on practical action, expanding testing and diagnosis, supporting community-based care, reducing stigma, and ensuring that services reach the communities most affected.
To keep the momentum going, the Albanese Government has partnered with Hepatitis Australia to coordinate a sector-wide process to design the action plans to implement the strategies in partnership with the Australian Centre for Disease Control.
This work will help turn national priorities into clear, practical steps on the ground.
The strategies build on existing Government investment so Australians can live free from the impact of hepatitis B and C, including:
- $23.7 million to support on-the-ground hepatitis B and C initiatives, including for point-of-care testing, treatment and care, and pilot hepatitis B programs
- $51.7 million over 3 years to continue the national viral hepatitis elimination program.
